OR Edge Morning Report | Issue 006 Guiding Every Case to Certainty and Calm

A single denied claim for a total knee arthroplasty puts $11,400 or more at-risk revenue. That is one case. One denial. One documentation gap that the AI found before your billing team did.

Beyond the lost claim value, each reworked denial costs between $25 and $118 in administrative labor. And 50% to 60% of denied claims are never followed up at all; they age from denied to written off without a single appeal.

Florida ASCs are now facing that exposure from two separate payer systems, running simultaneously, on the same patient, on the same scheduled case. The CMS Prior Authorization Demonstration launched on December 15, 2025. Your Medicare Advantage plans were already running their own AI denial logic before that date. You are not navigating one authorization gauntlet. You are navigating two, and the financial consequence of losing either one is not recoverable.

On that date, CMS launched the ASC Prior Authorization Demonstration, a five-year federal program targeting specific high-volume procedures performed in ambulatory surgery centers. Florida is one of the ten states in scope. The program went live with no grace period and no widely distributed operational briefing to independent ASC teams.

The procedures in scope are not obscure. They are the bread and butter of independent South Florida ASCs: arthroscopic knee procedures, epidural steroid injections, vertebroplasty and kyphoplasty, percutaneous lumbar decompression, and skin and tissue substitute applications. If your center runs orthopedic, spine, or pain management cases, your schedule is directly affected right now.

That is what this issue is about.

The payer mix that no other market has to manage

South Florida has some of the highest Medicare Advantage penetration rates in the US. Miami-Dade County is around 74%, and Broward County is nearing 60%. For independent ASC administrators in this region, this means that most of your Medicare volume is already processed through Medicare Advantage plans, not traditional fee-for-service Medicare. Medicare Advantage plans are not bound by CMS demonstration timelines or turnaround requirements. They operate their own prior authorization systems, AI algorithms, and denial logic, with no federal mandates on response times or gold card exemption programs for high-performing providers. You are managing two authorization systems simultaneously on the same patient, for the same scheduled case.

Prior authorization requirements now apply to approximately 46% of ASC cases nationally. In South Florida, because of your payer mix, your exposure is structurally higher than centers in almost any other market in the country.

Florida's prior authorization burden is compounded by two additional dynamics unique to this market. Miami-Dade, Broward, and Palm Beach counties carry a disproportionately high concentration of Medicare-eligible patients with complex chronic disease burdens, multiple comorbidities, and polypharmacy profiles. The margin for documentation gaps is zero. And independent ASCs in South Florida compete directly against Baptist Health South Florida, HCA Healthcare, Broward Health, and Memorial Health System; all of which are actively expanding their outpatient surgical footprint in 2026. These health systems have dedicated prior authorization teams, centralized revenue cycle infrastructure, and enterprise-level technology platforms. Independent centers are running the same authorization gauntlet with a fraction of the administrative resources.

The playing field is not level. The workflow has to compensate for that gap.

What the floor is telling me

I have watched it happen more than once.

A patient arrives at registration on the morning of surgery. Everything looks ready. The room is set. The surgeon is there. The staff is prepped. And then someone at the front desk discovers the prior authorization was never confirmed. It was initiated weeks ago, followed up on twice, and then it fell through a gap in the workflow that nobody owns.

What happens next is not just an administrative problem. The patient is anxious and confused. The surgeon is watching the clock because a delayed first case is a compressed schedule for every case that follows. The nursing team is being asked to move faster through a pre-op process that was designed to be thorough, not rushed. And somewhere in that pressure, steps get skipped. Not because anyone is careless. Because the system created conditions where rushing felt like the only option.

The OR sits idle. The revenue disappears. And the root cause was a workflow gap that existed weeks before that patient walked through the door.

That gap is where same-day cancellations are born.

What the AI is actually doing, and why it matters for your workflow

Most administrators understand that payers are using AI to process authorization requests. However, what is less understood is how these systems are structured to make decisions and what that means for how you submit.

Under the CMS WISeR model, technology companies are contracted to review prior authorization requests using artificial intelligence and machine learning, alongside human clinical review. Coverage decisions are expected within 72 hours for standard reviews and 48 hours for expedited cases.

Here's what changes how you should read every denial you receive: The technology companies running these AI review systems are compensated based on a percentage of the observed cost savings generated from requests that were reviewed but did not lead to a paid claim. The system is designed to reduce utilization. Denials are not incidental to the model; reduced paid claims are the financial outcome that the model is built to produce.

The AI does not read your chart the way a clinician would. It pattern-matches your submitted documentation against the coverage criteria for that procedure code. If the documentation does not map directly, explicitly, and completely to the National Coverage Determination or Local Coverage Determination criteria, the algorithm flags it, and a human reviewer may never see it before a denial is generated.

This means the quality and structure of your pre-authorization documentation is not a billing department responsibility; it is a clinical workflow responsibility that begins the moment a case is scheduled.

What the AI is actually doing, and why it matters for your workflow

Most administrators understand that payers are using AI to process authorization requests. What is less understood is how these systems are structured to make decisions, and what that means for how you submit.

Under the CMS WISeR model, technology companies are contracted to review prior authorization requests using artificial intelligence and machine learning alongside human clinical review. Coverage decisions are expected within 72 hours for standard reviews and 48 hours for expedited cases.

Here is the part that changes how you should read every denial you receive.

The technology companies running these AI review systems are compensated based on a percentage of the observed cost savings generated from requests that were reviewed but did not lead to a paid claim. The system is designed to reduce utilization. Denials are not incidental to the model. Reduced paid claims are the financial outcome that the model is built to produce.

The AI does not read your chart the way a clinician would. It pattern-matches your submitted documentation against the coverage criteria for that procedure code. If the documentation does not map directly, explicitly, and completely to the National Coverage Determination or Local Coverage Determination criteria, the algorithm flags it. A human reviewer may never see it before a denial is generated.

This means the quality and structure of your pre-authorization documentation is not a billing department responsibility. It is a clinical workflow responsibility that begins the moment a case is scheduled.

Five workflow moves that increase your approval rate

These are not general best practices. They are specific, sequenced actions that address how AI-driven authorization systems process and score submitted documentation.

One. Start the authorization clock at scheduling, not at pre-op.

The single most common authorization failure pattern in independent ASCs is initiating the authorization request too late. When authorization is treated as a pre-op task, it competes with clinical preparation for the same staff hours and the same deadline. Authorization confirmation should be a scheduling checkpoint, not a clinical one. The moment a case is booked, authorization status becomes a tracked item with a resolution deadline of Day 10 before surgery. If authorization is not confirmed by Day 7, it escalates as a workflow flag, parallel to medication and documentation gaps.

Two. Map your documentation directly to the NCD or LCD criteria before submission, not after denial.

Every procedure covered under the CMS ASC demonstration and every Medicare Advantage medical necessity policy has published coverage criteria. Those criteria include specific clinical indicators, conservative treatment failure requirements, imaging recency standards, and, in some cases, trial period documentation. The AI reviewing your submission is checking your documentation against the criteria list explicitly. If your clinical notes describe a medically necessary procedure in narrative language but do not explicitly address each required criterion, the algorithm will score the submission as incomplete. Build a procedure-specific documentation checklist for every covered service your center performs, keyed to the exact language of the applicable NCD or LCD. Submit documentation that mirrors the criteria structure, not just the clinical picture.

Three. Designate an authorization coordinator who is not your pre-op nurse.

When authorization management falls to pre-op nurses, two things happen simultaneously. Clinical preparation quality decreases because attention is divided. And authorization follow-up degrades because it competes with patient-facing responsibilities that cannot be deferred. Authorization tracking is an administrative function. It requires persistence, documentation skills, and familiarity with payer-specific portals. It does not require clinical licensure. Separating this function protects your nurses' capacity for the work only they can do.

Four. Build your approval history now; before gold carding is available.

CMS has confirmed it intends to pilot a gold carding exemption feature by mid-2026. Providers with consistent authorization approval histories will be eligible for exemption from future prior authorization or pre-payment review requirements. The centers that earn that exemption earliest are the ones that have been submitting clean, complete, criteria-matched documentation consistently since the demonstration launched. Every clean approval your center generates right now is a data point in your future exemption application. The operational investment in documentation quality today has a compounding return.

Five. Track authorization expiration dates on your surgical schedule.

Once a prior authorization is approved, it is valid for 120 calendar days from the approval date. A case rescheduled outside that window requires a new authorization submission, restarting the review timeline and creating a new denial risk. Add authorization expiration dates as a visible field in your scheduling system alongside the procedure date. Flag any case where the expiration window is closing within 30 days, and the procedure has not yet been completed.

What to do this week

Pull your prior authorization denial log from the last 90 days. Sort by procedure category. If arthroscopic knee, epidural steroid injections, lumbar decompression, vertebroplasty, or skin substitute cases appear more than twice, your documentation workflow for those procedures needs to be rebuilt against the current NCD and LCD criteria before the next submission.

If you do not have a denial log, that is the first thing to build. You cannot fix a pattern you have not measured.

The tool that strengthens your foundation

Before you can optimize your authorization documentation, your pre-op intake workflow needs to be solid. Medication reconciliation, clearance confirmation, and clinical gap identification are the foundation that every authorization submission rests on.

The ASC Pre-Op Audit Checklist walks you through 20 critical checkpoints in your current pre-op intake process across four clinical sections. It scores your workflow, identifies your highest-priority gaps, and generates a printed action plan you can take into your next leadership meeting.

It takes 10 minutes. The findings will shape how you approach both pre-op preparation and authorization documentation for the rest of 2026.

Curated intelligence from the perioperative space this week.

The CMS Demonstration Reality: On December 15, 2025, CMS launched the ASC Prior Authorization Demonstration, a five-year federal program targeting specific high-volume procedures in ambulatory surgery centers across ten states. Florida is in scope with no grace period and no widely distributed operational briefing to independent teams. If your center runs orthopedic, spine, or pain management cases, your schedule is directly affected right now.

The WISeR Overlap: The prior authorization demonstration runs concurrently with the WISeR Model (Wasteful and Inappropriate Service Reduction; a separate CMS initiative using AI and machine learning to flag procedures for prepayment review across six states). If your center operates across multiple states, your compliance exposure is layered, and each state carries its own effective date and MAC contact.

The Surgical Smoke Update: Twenty states now have mandatory surgical smoke evacuation laws. If your state is not yet one of them, watch your 2026 legislative calendar. This is moving faster than most administrators anticipated.

The GLP-1 Gap: Your intake form likely screens for Ozempic. Does it screen for Tirzepatide, the active ingredient in Mounjaro and Zepbound? Same aspiration risk profile. Different brand name. Patients do not connect the two. Your pre-op team is the last line of detection before that patient reaches your OR.

The prior authorization failure I described above is not a billing department problem. It is a clinical workflow problem that begins the moment a case is scheduled.

When authorization tracking falls to pre-op nurses, two things happen simultaneously. Clinical preparation quality decreases because attention is divided between administrative follow-up and patient-facing responsibilities. And authorization follow-up degrades because it competes with tasks that cannot be deferred.

The result is a patient in a holding area, anxious and unprepared for the delay, and a nursing team being asked to rush through the exact checklist steps designed to protect that patient's safety.

That is not a billing failure. That is a systems failure. And it is preventable.

Build the workflow before the next denial shows you where the gap is.

The checklist I built exists because I kept watching that gap go unfilled.

Build the workflow before the next case hits the board.

Brief comment before closing out this edition!

Know an ASC administrator or OR manager who needs this? Forward this issue or send it directly here: oredgemorningreport.com/subscribe Free. No fluff. Written from the floor through a Perioperative RN, who has been living the same as you every single day!

Do the audit this week, before you need to!

The centers navigating 2026 are the ones that built their systems before the crisis arrived. Those that didn't are rebuilding them now, under pressure, with compromised leverage, and a full schedule on the board.

You have time right now. Use it!

What to watch in Issue 007

Your patients are not the same as they were five years ago. Their medication lists, their implanted devices, and their comorbidity profiles have changed faster than most ASC clinical policies have been updated. Issue 007 will cover the three medication classes most commonly missed in pre-op intake for higher acuity cases, including one that carries a life-threatening surgical risk even when blood sugar looks completely normal. If you are scheduling cardiac or spine procedures in 2026, that issue was written for your team.

Forward this issue to your director of nursing or ASC administrator. They need to see this before their next case scheduling meeting.

See you Tuesday at 6:00 AM EST.

With purpose,

Yetsenia Tyson, RN.

Founder and CEO.

Haleris OR Edge Morning Report

oredgemorningreport.com

Sources and Methodology

All data cited in this issue is sourced from verifiable published references. Every statistic is verified against its source before publication.

OR Edge Morning Report maintains a strict data integrity standard. We verify every statistic against its source before publication. If you identify a discrepancy, please reply directly to this email.

If this landed with you, forward it to an independent ASC administrator or surgical director in your network who is currently navigating anesthesia coverage. They likely need this information more than they realize.

Reply with what you are seeing on the Pre-op front at your center. I read every response.

Tuesday at 6:00 AM EST.

Yetsenia Tyson, RN.

Founder, Haleris

Publisher, OR Edge Morning Report